UnknownPhase 2/3

Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA

30 participantsStarted 2022-10-01

Plain-language summary

This is a double-blinded randomized controlled trial aims to evaluate the effect of preemptive analgetic combination of celecoxib and pregabalin to acute pain after total hip arthroplasty. This study will be conducted in Cipto Mangunkusumo Hospital, Jakarta, Indonesia, from October 2022 to April 2023. The subject of this study is adult patient who will be performed total hip arthroplasty.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients \>18 years old
✓. Patients who come to the RSCM Orthopedic Polyclinic
✓. Patients undergoing THA operasi surgery
✓. Patients with Primary and Secondary Pelvic Osteoarthritis
✓. The patient is taking anti-pain and anti-inflammatory drugs regularly

Exclusion criteria

✕. Patients with mental disorders
✕. Patients with a history of renal impairment
✕. Pelvic arthritis patients due to rheumatoid arthritis or infection
✕. Patients with diabetes and obesity
✕. Allergy to non-steroidal inflammatory drugs
✕. Asthma history
✕. Coagulation disorders

What they're measuring

Postoperative Pain

Timeframe: After surgery for three days

Total consumption of morphine

Timeframe: Three days

Trial details

NCT IDNCT05509946

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-01

Contact for this trial

Kemas MA Novriandi, MD

+628194830011 Azkanovriandi1991@gmail.com

View on ClinicalTrials.gov More Arthroplasty Complications trials